I kliniske forsøg anbefaledes det, at behandling med imatinib seponeredes mindst 7 dage inden påbegyndelse af behandling med SPRYCEL.
In clinical trials, it was recommended that treatment with imatinib be discontinued at least 7 days before starting treatment with SPRYCEL.